{"id":1704,"date":"2020-11-12T07:00:00","date_gmt":"2020-11-12T07:00:00","guid":{"rendered":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/"},"modified":"2024-08-06T12:25:13","modified_gmt":"2024-08-06T12:25:13","slug":"en-framgangsrik-emission-med-fokus-pa-forsaljning","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/","title":{"rendered":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<div>\n<p>Press release (MAR)<\/p>\n<p>Malm\u00f6, 12 november, 2020<\/p>\n<p><strong>Acarix AB (publ) publicerar del\u00e5rsrapport, januari \u2013 september 2020<\/strong><\/p>\n<p><strong>En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!<\/strong><\/p>\n<p>Under tredje kvartalet s\u00e5g vi ett \u00f6kat intresse f\u00f6r v\u00e5rt anv\u00e4ndarv\u00e4nliga diagnostiska test. Under kvartalet har vi levererat 14 CADScor\u00aeSystem, vilket \u00e4r v\u00e5rt b\u00e4sta kvartal hittills. Framg\u00e5ngen baseras fr\u00e4mst p\u00e5 en stark utveckling i Tyskland, \u00d6sterrike och Schweiz, men vi mottog ocks\u00e5 v\u00e5ra f\u00f6rsta order i Mellan\u00f6stern vilket bidrog till det positiva resultatet. I kombination med f\u00f6rs\u00e4ljning av v\u00e5ra eng\u00e5ngspl\u00e5ster motsvarar detta en betydande oms\u00e4ttningstillv\u00e4xt j\u00e4mf\u00f6rt med samma tid f\u00f6reg\u00e5ende \u00e5r.<\/p>\n<p><em>Utdrag ur VD Per Perssons kommentar till del\u00e5rsrapporten.<\/em><\/p>\n<p><strong>Tredje kvartalet 2020 j\u00e4mf\u00f6rt med samma period 2019<\/strong><\/p>\n<ul type=\"disc\">\n<li>Under tredje kvartalet s\u00e5ldes 14 (3) CADScor\u00aeSystem och 1\u00a0320 (496) eng\u00e5ngspl\u00e5ster till b\u00e5de slutf\u00f6rbrukare och distribut\u00f6rer.<\/li>\n<li>Int\u00e4kterna uppgick till 791 kSEK (120), med ett bruttoresultat om 552 kSEK (74) och en bruttomarginal om 70 procent (62).<\/li>\n<li>R\u00f6relsekostnaderna uppgick till 9\u00a0440 kSEK (11\u00a0401).<\/li>\n<li>Resultat f\u00f6re skatt uppgick till \u20138\u00a0880 kSEK (\u201311\u00a0324).<\/li>\n<li>Kassafl\u00f6det fr\u00e5n den l\u00f6pande verksamheten uppgick till \u20136\u00a0418 kSEK (\u201311\u00a0002). Periodens nettokassafl\u00f6de, efter erh\u00e5llen emissionslikvid om netto 47\u00a0536 kSEK, uppgick till 40\u00a0951 kSEK.<\/li>\n<li>Resultat per aktie uppgick till \u20130,11 SEK (\u20130,49). Inga utsp\u00e4dningseffekter uppkom.<\/li>\n<\/ul>\n<p><strong>F\u00f6rsta nio m\u00e5naderna 2020 j\u00e4mf\u00f6rt med samma period 2019 <\/strong><\/p>\n<ul type=\"disc\">\n<li>Under de f\u00f6rsta nio m\u00e5naderna s\u00e5ldes totalt 20 (13) CADScor\u00aeSystem och 2\u00a0120 (2\u00a0826, inklusive 1\u00a0100 s\u00e5lda till bolagets kliniska pr\u00f6vningar) eng\u00e5ngspl\u00e5ster, vilket generade int\u00e4kter p\u00e5 1\u00a0204 kSEK (1\u00a0083) med ett bruttoresultat om 881 kSEK (823), motsvarande en bruttomarginal p\u00e5 73 procent (76).<\/li>\n<li>R\u00f6relsekostnaderna uppgick till 30\u00a0925 kSEK (37\u00a0283).<\/li>\n<li>Resultat f\u00f6re skatt uppgick till \u201330\u00a0085 kSEK (\u201336\u00a0447).<\/li>\n<li>Kassafl\u00f6det fr\u00e5n den l\u00f6pande verksamheten uppgick till \u201324\u00a0141 kSEK (\u201336\u00a0411). Inklusive erh\u00e5llen emissionslikvid uppgick periodens nettokassafl\u00f6de till 22\u00a0698 kSEK (\u201337\u00a0537).<\/li>\n<li>Beh\u00e5llning av likvida medel uppgick till 76\u00a0413 kSEK (27\u00a0685).<\/li>\n<li>Resultat per aktie uppgick till \u20130,49 SEK (\u20131,58). Inga utsp\u00e4dningseffekter uppkom.<\/li>\n<\/ul>\n<p><strong>H\u00e4ndelser under tredje kvartalet 2020<\/strong><\/p>\n<ul type=\"disc\">\n<li>Den 15 juli 2020 meddelade bolaget att styrelsen, under f\u00f6ruts\u00e4ttning av extra bolagsst\u00e4mmas godk\u00e4nnande, beslutat om en garanterad f\u00f6retr\u00e4desemission om h\u00f6gst 86\u00a0156\u00a0738 aktier som vid full teckning ber\u00e4knades tillf\u00f6ra bolaget cirka 56 MSEK f\u00f6re avdrag f\u00f6r kostnader.<\/li>\n<li>Extra bolagsst\u00e4mma h\u00f6lls den 11 augusti 2020 f\u00f6r att godk\u00e4nna emissionen. Dessutom beslutades att utf\u00e4rda 3\u00a0000\u00a0000 teckningsoptioner till nyckelpersoner i bolaget.<\/li>\n<li>Den 3 september meddelade f\u00f6retaget att det tyska h\u00e4lsoministeriet har tillk\u00e4nnagivit att fonokardiografi f\u00f6r att utesluta kransk\u00e4rlssjukdomar har potential f\u00f6r allm\u00e4n anv\u00e4ndning i Tyskland. Den tyska gemensamma federala kommitt\u00e9n (G-BA) har angivit huvuddragen i de grundl\u00e4ggande delar en eventuell studie b\u00f6r innefatta. Studien ska utf\u00f6ras av en oberoende vetenskaplig institution och enligt uppsatta riktlinjer fr\u00e5n G-BA. \u201dV\u00e4gledningen fr\u00e5n G-BA bekr\u00e4ftar det kliniska v\u00e4rdet och relevansen av v\u00e5r CADScor\u00ae-teknik\u201d, s\u00e4ger Per Persson, VD f\u00f6r Acarix.<\/li>\n<li>Den 11 september tillk\u00e4nnagav bolaget att emissionen tecknades till totalt cirka 123 procent och inbringade cirka 56 MSEK f\u00f6re kostnader.<\/li>\n<li>Den 29 september 2020 meddelade bolaget att en riktad nyemission genomf\u00f6rts till de garanter i f\u00f6retr\u00e4desemissionen som valt att erh\u00e5lla garantiers\u00e4ttning i form av nyemitterade aktier.<\/li>\n<\/ul>\n<p><strong>H\u00e4ndelser efter den 30 september 2020<\/strong><br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00b7Den 15 oktober har bolaget ing\u00e5tt avtal med Redeye AB avseende tj\u00e4nsten som Certified Adviser. Redeye AB tilltr\u00e4dde som Certified Adviser den 19 oktober 2020.<\/p>\n<p>Den fullst\u00e4ndiga del\u00e5rsrapporten finns tillg\u00e4nglig via l\u00e4nk nedan samt p\u00e5 www.acarix.com<\/p>\n<p><strong>Kontaktpersoner f\u00f6r mer information <\/strong><\/p>\n<p>Per Persson, VD <br \/>e-post: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-CL2iYcLU15TeJi6Ihj1JrX2KjVKNasnkDi-WXD15IDuUR_f8g_s1B9pjsQB0zrVCF9kvpirrIf4rlui9OjXA3B3YkbwmBVe88OipytzZxc=\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>per.persson@acarix.com<\/u><\/a> <br \/>tel: +46 736 005\u00a0990<\/p>\n<p>Christian Lindholm, CFO <br \/>e-post: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CpagOe_Q4jXKaU-YdpiksgYzQamXA0mz4f-kZTmugbGaz98DQogoXGQCi1uJ3rIYhtk94KC2u78L14fzl-k5WrK12U9NMNcNO3n2IMS34rlWHe5-xnMl8MPMJOhyTOAn\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>christian.lindholm@acarix.com<\/u><\/a><br \/>tel: +46 705 118\u00a0333<\/p>\n<p><strong>Om Acarix<\/strong><br \/>Acarix grundades 2009 och \u00e4r noterat p\u00e5 Nasdaq First North Premier. Acarix CADScor\u00aeSystem anv\u00e4nder en avancerad sensor som placeras p\u00e5 huden ovanf\u00f6r hj\u00e4rtat f\u00f6r att lyssna p\u00e5 ljudet av hj\u00e4rtkontraktion och turbulent fl\u00f6de. Det har utformats f\u00f6r att vara ett allt-i-ett-system i den meningen att signalen fr\u00e5n hj\u00e4rtat spelas in, bearbetas och visas som en patientspecifik s.k. CAD-score p\u00e5 sk\u00e4rmen. Presentation av m\u00e4tresultaten erh\u00e5lls p\u00e5 mindre \u00e4n 8 minuter. Som en s\u00e4ker metod och l\u00e4mplig f\u00f6r anv\u00e4ndning i b\u00e5de prim\u00e4rv\u00e5rden och p\u00e5 inneliggande patienter kan CADScor\u00aeSystem potentiellt komma att spela en viktig roll f\u00f6r patient-triage, n\u00e5got som g\u00f6r att m\u00e5nga patienter inte beh\u00f6ver unders\u00f6kas ytterligare med invasiva, diagnostiska metoder.<\/p>\n<p><em>Denna <\/em><em>information <\/em><em>\u00e4r regulatorisk information som Acarix AB (publ)<\/em> <em>ska offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning.<\/em> <em>Informationen l\u00e4mnades f\u00f6r publicering genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg den 12 november 2020 kl 08.00.<\/em><\/p>\n<p>\u00a0<\/p>\n<p><\/div>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/efd057e4-caf5-466c-9850-d95994390873.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Acarix Del\u00e5rsrapport Q3 2020<\/a><br \/><a href=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2024\/08\/faca79fd-9ed1-40ab-9b8a-dbe1d877eb99.pdf\" target=\"_blank\" rel=\"nofollow noopener\">PM_Acarix_Q3_2020 sv<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Press release (MAR) Malm\u00f6, 12 november, 2020 Acarix AB (publ) publicerar del\u00e5rsrapport, januari \u2013 september 2020 En framg\u00e5ngsrik emission med<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[62,63,70,71,77],"class_list":["post-1704","post","type-post","status-publish","format-standard","hentry","category-press","tag-regulatory","tag-regulatorymar","tag-subreport","tag-subreportinterim","tag-subreportinterimq3"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix\" \/>\n<meta property=\"og:description\" content=\"Press release (MAR) Malm\u00f6, 12 november, 2020 Acarix AB (publ) publicerar del\u00e5rsrapport, januari \u2013 september 2020 En framg\u00e5ngsrik emission med\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-06T12:25:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"headline\":\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!\",\"datePublished\":\"2020-11-12T07:00:00+00:00\",\"dateModified\":\"2024-08-06T12:25:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/\"},\"wordCount\":789,\"keywords\":[\":regulatory\",\":regulatory:mar\",\"sub:report\",\"sub:report:interim\",\"sub:report:interim:q3\"],\"articleSection\":[\"Press\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/\",\"name\":\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2020-11-12T07:00:00+00:00\",\"dateModified\":\"2024-08-06T12:25:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix","og_description":"Press release (MAR) Malm\u00f6, 12 november, 2020 Acarix AB (publ) publicerar del\u00e5rsrapport, januari \u2013 september 2020 En framg\u00e5ngsrik emission med","og_url":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/","og_site_name":"Acarix","article_published_time":"2020-11-12T07:00:00+00:00","article_modified_time":"2024-08-06T12:25:13+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"headline":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!","datePublished":"2020-11-12T07:00:00+00:00","dateModified":"2024-08-06T12:25:13+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/"},"wordCount":789,"keywords":[":regulatory",":regulatory:mar","sub:report","sub:report:interim","sub:report:interim:q3"],"articleSection":["Press"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/","url":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/","name":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2020-11-12T07:00:00+00:00","dateModified":"2024-08-06T12:25:13+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/1704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=1704"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/1704\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=1704"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=1704"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=1704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}